EUVIMEDEUVIMED entdecken
Open Access

Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma

Yu Chen, Yupeng Jiang iD, Xionghui Li, Hong Huang, Yangying Zhou, Chenzi Zhang, Shunjun Wang, Hanibal Bohnenberger, Yawen Gao

Translational Lung Cancer Research · 2024-05 · 13 (5) · 1084-1100

DOI: 10.21037/tlcr-24-245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2024-05. Verfasst von Yu Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vitamins, and their metabolic processes play essential regulatory roles in controlling proliferation, differentiation, and growth in carcinogenesis. However, the role of vitamin metabolism in lung adenocarcinoma (LUAD) has rarely been reported. Here, we established a novel prognostic model based on vitamin metabolism-related genes in LUAD.

Methods

In this research, we aimed to identify vitamin metabolism associated with differentially expressed genes (DEGs) in LUAD utilizing The Cancer Genome Atlas (TCGA)-LUAD, GSE68465 and GSE72094 data. Unsupervised clustering classified patients into distinct subgroups. By utilizing least absolute shrinkage and selection operator (LASSO)-Cox regression analysis, vitamin metabolism-related genes could be used to construct prognostic model. Then the vitamin metabolism gene-related risk score (VRS) was calculated based on best cut-off splitting. Kaplan-Meier analysis, time-dependent receiver operating characteristic (ROC) analysis, univariate and multivariate Cox analyses, chemotherapeutic drugs sensitivity analysis, immune infiltration analysis and nomogram were conducted to verify our models' accuracy. Finally, CPS1 was identified as a relevant diagnostic marker using Random Forests algorithms, single-cell RNA sequencing data was used to confirm its expression.

Results

We investigated the relationship between vitamin metabolism patterns, overall survival (OS), and immune infiltration levels of patients with LUAD. A prognostic signature consisting of 11 genes was developed, which was able to classify patients into high and low VRS groups. Through gene enrichment analysis, cell cycle was mainly enriched. Compared to the low VRS group, the high VRS group exhibited poorer OS, as demonstrated by the Kaplan-Meier survival analysis. Furthermore, VRS was identified as an independent predictor of poor prognosis and poor OS, as indicated by both univariate and multivariate Cox regression analyses. Additionally, a nomogram was constructed to improve the accuracy of survival predictions in LUAD patients. We also found that the two groups of patients might respond differently to immune targets and anti-tumor drugs. CPS1 was identified as a relevant diagnostic marker and the expression was also as confirmed by single-cell RNA sequencing data.

Conclusions

Overall, our findings suggest that vitamin metabolism can influence the prognosis of LUAD patients, and our prognostic signature represents a potentially helpful resource for predicting patient outcomes and informing clinical decision-making.

Schlagwörter

Stichwörter der Autor:innen

Vitamin metabolismlung adenocarcinoma (LUAD)prognosissignature

Autor:innen und Institutionen

  • Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Critical Medicine, Hunan Academy of Traditional Chinese Medicine Affiliated Hospital, Changsha, China.
  • Department of Clinical Medicine, Guilin Medical University, Guilin, China.
  • Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Chest Surgery, Qinghai Red Cross Hospital, Xining, China.

ORCID-Profile: Yupeng Jiang

Zitieren

APA

Chen, Y., Jiang, Y., Li, X., Huang, H., Zhou, Y., Zhang, C., Wang, S., Bohnenberger, H., & Gao, Y. (2024). Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma. Translational Lung Cancer Research, 13(5), 1084-1100. https://doi.org/10.21037/tlcr-24-245

Vancouver

Chen Y, Jiang Y, Li X, Huang H, Zhou Y, Zhang C, et al. Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma. Translational Lung Cancer Research. 2024;13(5):1084-1100. doi:10.21037/tlcr-24-245

BibTeX
@article{Chen2024,
  author = {Chen, Yu and Jiang, Yupeng and Li, Xionghui and Huang, Hong and Zhou, Yangying and Zhang, Chenzi and Wang, Shunjun and Bohnenberger, Hanibal and Gao, Yawen},
  title = {Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma},
  journal = {Translational Lung Cancer Research},
  year = {2024},
  volume = {13},
  number = {5},
  pages = {1084--1100},
  doi = {10.21037/tlcr-24-245}
}
Kostenlos starten →